Frewen T C, Sumabat W O, Han V K, Campbell K, Tiffin N
Department of Paediatrics, Children's Hospital of Western Ontario, London, Canada.
Crit Care Med. 1989 Sep;17(9):912-6. doi: 10.1097/00003246-198909000-00015.
Therapies including hyperventilation (HV) and hypothermia (HT) are currently simultaneously used in brain-injured children at risk for cerebral swelling to reduce cerebral blood flow (CBF) and alter cerebral metabolic rate for oxygen (CMRO2). Since HV and HT may contribute to significant patient morbidity, we evaluated the effects of these treatments in combination on CBF, CMRO2, and cross-brain oxygen extraction (CBO2) using the Kety-Schmidt technique before controlled bleeding to alter blood viscosity in 20 lightly anesthetized, paralyzed cats, and after bleeding in another 17 cats. The degree of HV (PaCO2 24 to 26 torr) and HT (32 degrees and 30 degrees C) used were representative of that employed in pediatric neurointensive care. HV at normothermia resulted in a significant decline in CBF (P less than .05) and an unchanged CMRO2. HV and HT together to 32 degrees C resulted in a further significant fall in CBF and CMRO2 (p less than .05), but an unchanged CBO2. Further cooling of the animal to 30 degrees C during HV, both before and after controlled bleeding, resulted in no further significant fall in CBF, CBO2, or CMRO2. This relationship was found despite a significant fall in Hgb (p less than .001), suggesting that blood viscosity did not significantly influence CBF at this temperature. Our data suggest that HT to 32 degrees C during HV may have therapeutic benefit by decreasing CBF and CMRO2, but further cooling to 30 degrees C may not result in further cerebral protective effects.
目前,包括过度通气(HV)和低温治疗(HT)在内的疗法同时应用于有脑肿胀风险的脑损伤儿童,以减少脑血流量(CBF)并改变脑氧代谢率(CMRO2)。由于HV和HT可能导致患者出现严重并发症,我们使用凯蒂 - 施密特技术评估了这两种治疗方法联合应用对CBF、CMRO2和跨脑氧摄取(CBO2)的影响。在20只轻度麻醉、麻痹的猫进行控制性出血以改变血液粘度之前,以及另外17只猫出血之后进行了评估。所用的HV程度(动脉血二氧化碳分压24至26托)和HT程度(32摄氏度和30摄氏度)代表了儿科神经重症监护中采用的程度。常温下的HV导致CBF显著下降(P小于0.05),而CMRO2不变。HV和HT联合降至32摄氏度导致CBF和CMRO2进一步显著下降(P小于0.05),但CBO2不变。在控制性出血前后,于HV期间将动物进一步冷却至30摄氏度,并未导致CBF、CBO2或CMRO2进一步显著下降。尽管血红蛋白显著下降(P小于0.001),但仍发现了这种关系,这表明在此温度下血液粘度对CBF没有显著影响。我们的数据表明,HV期间将体温降至32摄氏度可能通过降低CBF和CMRO2而具有治疗益处,但进一步冷却至30摄氏度可能不会带来进一步的脑保护作用。